Normothermic Ex Vivo Liver Platform Using Porcine Slaughterhouse Livers for Disease Modeling

Publication date

2022-09-14

Authors

Krüger, Melanie
Ruppelt, AliciaISNI 0000000526348395
Kappler, Benjamin
Van Soest, Elke
Samsom, Roos-AnneISNI 0000000512605717
Grinwis, Guy C MISNI 0000000394959548
Geijsen, NielsISNI 0000000396192432
Helms, J BerndISNI 0000000390424642
Stijnen, Marco
Kock, Linda M

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

cc_by

Abstract

Metabolic and toxic liver disorders, such as fatty liver disease (steatosis) and drug-induced liver injury, are highly prevalent and potentially life-threatening. To allow for the study of these disorders from the early stages onward, without using experimental animals, we collected porcine livers in a slaughterhouse and perfused these livers normothermically. With our simplified protocol, the perfused slaughterhouse livers remained viable and functional over five hours of perfusion, as shown by hemodynamics, bile production, indocyanine green clearance, ammonia metabolism, gene expression and histology. As a proof-of-concept to study liver disorders, we show that an infusion of free fatty acids and acetaminophen results in early biochemical signs of liver damage, including reduced functionality. In conclusion, the present platform offers an accessible system to perform research in a functional, relevant large animal model while avoiding using experimental animals. With further improvements to the model, prolonged exposure could make this model a versatile tool for studying liver diseases and potential treatments.

Keywords

hepatic diseases, machine perfusion, acetaminophen, steatosis

Citation

Krüger, M, Ruppelt, A, Kappler, B, Van Soest, E, Samsom, R A, Grinwis, G C M, Geijsen, N, Helms, J B, Stijnen, M, Kock, L M, Rasponi, M, Kooistra, H S & Spee, B 2022, 'Normothermic Ex Vivo Liver Platform Using Porcine Slaughterhouse Livers for Disease Modeling', Bioengineering (Basel, Switzerland), vol. 9, no. 9, 471, pp. 1-19. https://doi.org/10.3390/bioengineering9090471